Akoya Biosciences, Inc. logo AKYA - Akoya Biosciences, Inc.

Inactive Ticker AKYA is not actively trading. Quotes and analytics may be stale.
Price: -- --
Annual Quarterly
Metric 2025 Q1
Revenue
Revenue 16.6
Cost of Revenue 6.8
Gross Profit 9.9
Operating Expenses
R&D Expenses 5.6
SG&A Expenses 17.6
Other Expenses 0.1
Operating Expenses 23.3
Operating Income
Operating Income (13.4)
Interest Expense 2.5
Interest Income 0.3
Profitability
EBITDA (11.3)
EBIT (13.1)
Income Before Tax (15.6)
Income Tax Expense 0.0
Net Income (15.7)
Per Share Data
EPS (Basic) -0.32
EPS (Diluted) -0.32
Shares Outstanding 49.7
Metric 2025 Q1
Current Assets
Cash & Cash Equivalents 20.4
Short-Term Investments 7.2
Net Receivables 11.7
Inventory 22.9
Other Current Assets 4.1
Total Current Assets 66.2
Non-Current Assets
Property, Plant & Equipment 12.1
Goodwill 18.3
Intangible Assets 13.8
Long-Term Investments 0.7
Other Non-Current Assets 2.2
Total Non-Current Assets 46.4
Total Assets 112.6
Current Liabilities
Account Payables 10.3
Short-Term Debt 76.5
Deferred Revenue 7.6
Other Current Liabilities 1.9
Total Current Liabilities 108.1
Non-Current Liabilities
Long-Term Debt 0
Deferred Tax Liabilities 0.1
Other Non-Current Liabilities 3.5
Total Non-Current Liabilities 10.5
Total Liabilities 118.5
Stockholders' Equity
Common Stock 0.0
Retained Earnings (301.1)
Accumulated Other Comprehensive Income (0.0)
Total Stockholders' Equity (5.9)
Total Liabilities & Equity 112.6
Debt Metrics
Total Debt 83.7
Net Debt 63.4
Metric 2025 Q1
Operating Activities
Net Income (15.7)
Depreciation & Amortization 1.8
Stock-Based Compensation 2.2
Change in Working Capital 3.1
Other Non-Cash Items 1.2
Operating Cash Flow (7.2)
Investing Activities
Capital Expenditure (0.2)
Acquisitions 0
Purchases of Investments (3.8)
Sales/Maturities of Investments 20
Other Investing Activities 0
Investing Cash Flow 16.0
Financing Activities
Net Debt Issuance (0.2)
Stock Repurchased 0
Dividends Paid 0
Other Financing Activities 0.0
Financing Cash Flow (0.2)
Cash Position
Net Change in Cash 8.6
Cash at Beginning 12.5
Cash at End 21.0
Free Cash Flow (7.4)
Key Metrics 2025 Q1
Income Statement
Revenue 16.6
Gross Profit 9.9
Operating Income (13.4)
Net Income (15.7)
EPS (Diluted) -0.32
Balance Sheet
Cash & Equivalents 20.4
Total Assets 112.6
Total Debt 83.7
Stockholders' Equity (5.9)
Cash Flow
Operating Cash Flow (7.2)
Capital Expenditure (0.2)
Free Cash Flow (7.4)